Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Open-label placebo for major depressive disorder: a pilot randomized controlled trial.

Literature DB >> 22854752

Open-label placebo for major depressive disorder: a pilot randomized controlled trial.

John M Kelley, Ted J Kaptchuk, Cristina Cusin, Samuel Lipkin, Maurizio Fava.

Abstract

Entities: Chemical Disease Species

Mesh：

Substances：
Placebos

Year: 2012 PMID： 22854752 PMCID： PMC3813004 DOI： 10.1159/000337053

Source DB: PubMed Journal: Psychother Psychosom ISSN： 0033-3190 Impact factor: 17.659

× No keyword cloud information.

6 in total

1. A rating scale for depression.

Authors: M HAMILTON
Journal: J Neurol Neurosurg Psychiatry Date: 1960-02 Impact factor: 10.154

2. A power primer.

Authors: J Cohen
Journal: Psychol Bull Date: 1992-07 Impact factor: 17.737

3. Reliability and validity of the Symptoms of Depression Questionnaire (SDQ).

Authors: Paola Pedrelli; Mark A Blais; Jonathan E Alpert; Richard C Shelton; Rosemary S W Walker; Maurizio Fava
Journal: CNS Spectr Date: 2014-10-02 Impact factor: 3.790

4. The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression.

Authors: A John Rush; Madhukar H Trivedi; Hicham M Ibrahim; Thomas J Carmody; Bruce Arnow; Daniel N Klein; John C Markowitz; Philip T Ninan; Susan Kornstein; Rachel Manber; Michael E Thase; James H Kocsis; Martin B Keller
Journal: Biol Psychiatry Date: 2003-09-01 Impact factor: 13.382

Review 5. Placebo as a treatment for depression.

Authors: W A Brown
Journal: Neuropsychopharmacology Date: 1994-07 Impact factor: 7.853

6. Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration.

Authors: Irving Kirsch; Brett J Deacon; Tania B Huedo-Medina; Alan Scoboria; Thomas J Moore; Blair T Johnson
Journal: PLoS Med Date: 2008-02 Impact factor: 11.069

6 in total

55 in total

Review 1. The placebo effect: From concepts to genes.

Authors: B Colagiuri; L A Schenk; M D Kessler; S G Dorsey; L Colloca
Journal: Neuroscience Date: 2015-08-10 Impact factor: 3.590

2. Does Bismuth Subgallate Affect Smell and Stool Character? A Randomized Double-Blinded Placebo-Controlled Trial of Bismuth Subgallate on Loop Duodenal Switch Patients with Complaints of Smelly Stools and Diarrhea.

Authors: Hinali Zaveri; Amit Surve; Daniel Cottam; Walter Medlin; Christina Richards; Austin Cottam; Samuel Cottam
Journal: Obes Surg Date: 2018-11 Impact factor: 4.129

3. The Placebo Effect in Pain Therapies.

Authors: Luana Colloca
Journal: Annu Rev Pharmacol Toxicol Date: 2018-09-14 Impact factor: 13.820

4. Placebo response rates and potential modifiers in double-blind randomized controlled trials of second and newer generation antidepressants for major depressive disorder in children and adolescents: a systematic review and meta-regression analysis.

Authors: Ramona Meister; Mariam Abbas; Jochen Antel; Triinu Peters; Yiqi Pan; Ulrike Bingel; Yvonne Nestoriuc; Johannes Hebebrand
Journal: Eur Child Adolesc Psychiatry Date: 2018-12-08 Impact factor: 4.785

Open-label placebo for major depressive disorder: a pilot randomized controlled trial.

1. A rating scale for depression.

2. A power primer.

3. Reliability and validity of the Symptoms of Depression Questionnaire (SDQ).

4. The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression.

Review 5. Placebo as a treatment for depression.

6. Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration.

Review 1. The placebo effect: From concepts to genes.

2. Does Bismuth Subgallate Affect Smell and Stool Character? A Randomized Double-Blinded Placebo-Controlled Trial of Bismuth Subgallate on Loop Duodenal Switch Patients with Complaints of Smelly Stools and Diarrhea.

3. The Placebo Effect in Pain Therapies.

4. Placebo response rates and potential modifiers in double-blind randomized controlled trials of second and newer generation antidepressants for major depressive disorder in children and adolescents: a systematic review and meta-regression analysis.

Review 5. Role of placebo effects in pain and neuropsychiatric disorders.

6. Open label placebo: can honestly prescribed placebos evoke meaningful therapeutic benefits?

7. Altered placebo and drug labeling changes the outcome of episodic migraine attacks.

Review 8. Placebos Without Deception: Outcomes, Mechanisms, and Ethics.

Review 9. Placebo eff ects in psychiatry: mediators and moderators.

10. The placebo effect in psychiatric practice.